BackRoivant Sciences Overview
Roivant Sciences Ltd

Roivant Sciences Target Price

See Roivant Sciences's analyst price targets ($47) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$38.22

Average Target Price

$46.8622.6% upside

7 analysts in the last 4 months

High: $55 | Low: $36

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-16Stifel Nicolaus$5133.4% upsideOpen
2026-09-09GuggenheimYastin Suneja$4620.4% upsideOpen
2026-09-09UBS$5543.9% upsideOpen
2026-09-08H.C. Wainwright$4723% upsideOpen
2026-09-08Jefferies$5236.1% upsideOpen
2026-08-07H.C. WainwrightDouglas Tsao$417.3% upsideOpen
2026-05-26GuggenheimYastin Suneja$365.8% downsideOpen
2026-05-21Cowen & Co.$417.3% upsideOpen
2026-05-21Leerink PartnersDavid Risinger$429.9% upsideOpen
2026-04-16Piper Sandler$404.7% upsideOpen
2026-03-04H.C. WainwrightDouglas Tsao$3411% downsideOpen
2026-02-10H.C. Wainwright$3313.7% downsideOpen
2026-02-09Jefferies$3021.5% downsideOpen
2026-02-09Guggenheim$3021.5% downsideOpen
2025-12-18Guggenheim$2826.7% downsideOpen
2025-12-15Leerink PartnersDavid Risinger$3216.3% downsideOpen
2025-12-12H.C. Wainwright$2632% downsideOpen
2025-11-14GuggenheimYastin Suneja$2534.6% downsideOpen
2025-11-11Leerink PartnersDavid Risinger$2924.1% downsideOpen
2025-09-18Jefferies$2047.7% downsideOpen
2025-09-18Guggenheim$2145.1% downsideOpen
2025-09-18H.C. Wainwright$2047.7% downsideOpen
2024-10-21Leerink PartnersDavid Risinger$1755.5% downsideOpen
2024-09-19Goldman SachsCorinne Jenkins$1755.5% downsideOpen
2024-09-11Bank of America SecuritiesChi Fong$12.567.3% downsideOpen
2024-05-31Piper SandlerAllison Bratzel$2047.7% downsideOpen
2024-04-03H.C. WainwrightDouglas Tsao$1852.9% downsideOpen
2024-04-03Deutsche BankNeena Bitritto-Garg$1560.8% downsideOpen
2024-04-02Goldman SachsCorinne Jenkins$1852.9% downsideOpen
2024-03-13Goldman SachsCorinne Jenkins$1658.1% downsideOpen
2023-01-05Citigroup$1463.4% downsideOpen
2022-12-19Leerink Partners$1073.8% downsideOpen
2022-08-18Citigroup$1073.8% downsideOpen
2022-05-24Goldman Sachs$1268.6% downsideOpen

Roivant Sciences (ROIV) FAQ

Roivant Sciences's target price stands at $47. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $47 for ROIV implies 22.6% upside versus today's price ($38.22). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Roivant Sciences's target price evolved across reporting periods, while the comparison chart places ROIV next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.